Author: Yuefeng Rao, Qingwei Zhao, Xiangyi Zhang, Hongyu Yang, Yan Lou and Xingguo Zhang
Publishing Date: 2016
E-ISSN: 1011-601X
Volume: 29 Issue: 2
ABSTRACT:
In many industrialized countries, clinical pharmacy has developed into a separate discipline and become a vital part of inpatient care in hospitals. However, as compared to many established branches of medicine, clinical pharmacy is still in its infancy, with much room for growth, improvement, and recognition by both the medical community and patients. In this study, a widely-recognized development strategy analysis tool, Strength, Weakness, Opportunity and Threat (SWOT), was used to systematically address several key issues to the development of clinical pharmacy in China. This analysis aims to provide feasible recommendations for the development of clinical pharmacy in China by identifying current problems and growth opportunities. Full development of clinical pharmacy as a mature clinical discipline will help promote the rational use of drugs by both clinicians and patients and lead to enhanced drug efficacy and safety.
KEYWORDS: SWOT analysis; Clinical pharmacy; Hospital pharmacy; China.